Are you a passionate student, academic, clinician, innovator, or entrepreneur developing a game-changing technology to fight cancer? Cancer Tech Accelerator is now accepting applications for its 5th cohort!
Join a world-class programme designed to fast-track innovation and empower visionaries like you to make a lasting impact. 🚀
Backed by Cancer Research UK and Cancer Research Horizons, the Cancer Tech Accelerator (CTA) is the UK’s largest cancer tech accelerator, and has supported over 200 researchers and early innovators since 2021, helping them raise nearly $50 million in combined equity and grant funding.
Programme benefits include:
- Online and hybrid educational workshops tailored to the cancer tech journey like IP strategy, NHS procurement, market dynamics
- Bespoke mentoring with international experts on themes like oncology, market access, clinical validation, and growth
- Investor introductions and pitching opportunities top UK medtech funds
- Award funding pot totalling £250,000 in total in Phase II to catalyse your idea
- Perk packages that include access to web/server credits, legal support, discounted lab space, and more
- Dynamic cohort of peers and alumni across the cancer tech space
2026 is the year to turn your bold ideas into life-changing solutions for patients and providers.
If you have questions or want to refer an individual to the programme, please do not hesitate to reach out to us at medtech.ce@capitalenterprise.org or join one of our upcoming events.
Applications close 20 March! Start your application today: https://www.cancertechaccelerator.co.uk/
| Application Deadline |
20/03/2026 12:00nn |
| Application required? |
Apply Here |
